Evidence map›Paper›PMID 33383956›Full record

ArticleBiomolecules2020

Prophylactic Treatment with Vitamins C and B2 for Methotrexate-Induced Gastrointestinal Mucositis.

Ana Rita da Silva Ferreira, Hannah R Wardill, Rick Havinga, Wim J E Tissing, Hermie J M Harmsen

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Updated perspectives on the contribution of the microbiome to the pathogenesis of mucositis using the MASCC/ISOO framework.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Ana Rita da Silva FerreiraDepartment of Medical Microbiology, University of Groningen, University Medical Center Groningen, Hanzeplein 1 EB80, 9713 GZ Groningen, The Netherlands.
Hannah R WardillDepartment of Pediatrics, University of Groningen, University Medical Center Groningen, Hanzeplein 1 EB80, 9713 GZ Groningen, The Netherlands.ORCID 0000-0002-6613-3661
Rick HavingaDepartment of Pediatrics, University of Groningen, University Medical Center Groningen, Hanzeplein 1 EB80, 9713 GZ Groningen, The Netherlands.
Wim J E TissingDepartment of Pediatrics, University of Groningen, University Medical Center Groningen, Hanzeplein 1 EB80, 9713 GZ Groningen, The Netherlands.
Hermie J M HarmsenDepartment of Medical Microbiology, University of Groningen, University Medical Center Groningen, Hanzeplein 1 EB80, 9713 GZ Groningen, The Netherlands.
University Medical Center Groningen · NL

Funding

Marie Skłodowska Curie 713660NHMRC CJ Martin Biomedical Research Fellowship APP114092
6 · The paper itself

Abstract

Mucositis is a common side-effect of chemotherapy treatment, inducing alterations in the composition of the gut microbiota. Redox active compounds, such as vitamins B2 and C, have been shown to reduce inflammation and enhance the growth of anaerobic bacteria in the gut. We therefore aimed to (1) validate the ability of these compounds to promote bacterial cell growth in vitro, and (2) determine their prophylactic efficacy in a rat model of methotrexate (MTX)-induced mucositis. Bacterial growth curves were performed to assess the growth kinetics of bacteria exposed to Vitamins C and B2 (0.5 mM). Male wistar rats (150-200 g) received vitamins B2 (12 mg/day) and C (50 mg/day) via daily oral gavage (from day -1 to day 10). MTX (45 mg/Kg) was administrated via I.V. injection (N = 4-8/group) on day 0. Body weight, water/food consumption and diarrhea were assessed daily. Blood and faecal samples were collected longitudinally to assess citrulline levels (mucositis biomarker) and gut microbiota composition. Vitamins C/B2 enhanced the in vitro growth of anaerobic bacteria

Indexed as

AnimalsAntimetabolites, AntineoplasticAscorbic AcidGastrointestinal MicrobiomeMaleMethotrexateMucositisRats, WistarRiboflavinVitaminsAntimetabolites, AntineoplasticAscorbic AcidMethotrexateRiboflavinVitaminsanaerobic bacteriachemotherapy-induced mucositisgut microbiotamethotrexatevitamin B2vitamin C

Identifiers

PMID33383956
PMCPMC7823339
OpenAlexW3114232757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.